Producedon a contract
basis for «ORION CORPORATION» (Finland)
antitumor agent – antiestrogen.

ER-positive breast cancer in women (especially during menopause) and men.

The drug can be used for the treatment of ovarian cancer, endometrial cancer, kidney cancer, melanoma, soft tissue sarcomas with estrogen receptors in the tumor, as well as for the treatment of prostate cancer resistant to other drugs.

see instructions for use
Information about the availability of goods in pharmacies - 8-800-333-30-20